Home > News > ACLARA Signs GlaxoSmithKline to eTag™ Access Agreement
July 30th, 2003
ACLARA Signs GlaxoSmithKline to eTag™ Access Agreement
ACLARA BioSciences announced today that it has entered into an eTag™ Access Agreement with GlaxoSmithKline (GSK), under which GSK will gain access to ACLARA's proprietary eTag Assay System for use in its biopharmaceutical research and development activities.
UT Arlington researchers develop transparent nanoscintillators for radiation detection for medical safety and homeland security September 29th, 2014
Iranian Scientists Determine Grain Size, Minimize Time of Nanocomposite Synthesis September 29th, 2014
Nanoparticles Used to Improve Quality of Bone Cement September 29th, 2014
'Pixel' engineered electronics have growth potential: Rice, Oak Ridge, Vanderbilt, Penn scientists lead creation of atom-scale semiconducting composites September 29th, 2014